Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00096785 · ClinicalTrials.gov registry record · Phase 3

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

A Phase 3 study of Chronic Disease and Hepatitis B, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 3
Development phase
69
Enrollment target
20
Study locations

NCT00096785 is a Phase 3 study of Chronic Disease and Hepatitis B that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 69 participants, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00096785, a Phase 3 study of Chronic Disease and Hepatitis B, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 3
Development phase
69 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.

Conditions Studied

Chronic Disease Hepatitis B

Interventions

  • DRUG entecavir
  • DRUG adefovir

Study Locations (20)

Other

  • Local Institution - Chai Wan
  • Local Institution - Pokfulham
  • Local Institution - Tai Po
  • Local Institution - Jakarta
  • Local Institution - Cebu
  • Local Institution - Manila

California

  • Local Institution - San Diego
  • Local Institution - San Francisco
  • Local Institution - Torrance

Florida

  • Local Institution - Miami
  • Local Institution - North Miami Beach

New York

  • Local Insitution - New York
  • Local Institution - New York

Texas

  • Local Institution - Dallas
  • Local Institution - Galveston

Maryland

  • Local Institution - Baltimore

Pennsylvania

  • Local Institution - Philadelphia

Alberta

  • Local Institution - Edmonton

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2004-12
Est. Completion 2008-04
Phase Phase 3

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00096785

The ClinicalTrials.gov registry entry for NCT00096785 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 2 interventions - of which entecavir is the first listed.

NCT00096785 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00096785 about?

NCT00096785 is a clinical study titled "Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection". The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.

What is the current status of trial NCT00096785?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 69 participants. The study started on 2004-12. Estimated completion is 2008-04.

What conditions does trial NCT00096785 study?

This clinical trial studies the following conditions: Chronic Disease, Hepatitis B.

What interventions are being tested in trial NCT00096785?

The interventions under investigation include: entecavir (DRUG), adefovir (DRUG).

Who is sponsoring clinical trial NCT00096785?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00096785 being conducted?

This trial has 20 study locations across California, Florida, Maryland, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Disease

All registered trials for this condition

Hepatitis B

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.